Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Death row inmate whose execution was postponed found dead in cell

January 9, 2019 Research and Development Alvogen, Scott Dozier, execution, pharma, prison

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …
News

Super gonorrhoea on the rise, health officials warn

January 9, 2019 Research and Development STI, gonorrehoea, health, public health, std

Health officials from Public Health England (PHE) have warned that cases of antibiotic resistant strains of the sexually transmitted infection …
News

Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk

January 9, 2019 Manufacturing and Production, Research and Development India, Pfizer, pharma

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …
News
clostridium_difficile_cdc

Researchers explain link between anti-inflammatories and C. difficile

January 9, 2019 Research and Development C diff, C.Diff, Vanderbilt, anti-inflammatory, cdi, nsaids, research

In the past, observational studies have found a link between the use of common nonsteroidal anti-inflammatory drugs (NSAIDs) and increased …
News
nicola_redfern

bluebird bio reveals new UK General Manager

January 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions,  has named Nicola Redfern …
Appointment
jose_baselga

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Appointment
heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019 Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …
News
jallal

Immunocore names AstraZeneca exec as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …
Appointment
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
Appointment

How tech is powering precision treatment

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Feature
shutterstock_36423250

Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt

January 7, 2019 Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease

Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …
News
stocks1

Aevi Genomic Medicine’s share price crashes 75% following ADHD trial failure

January 4, 2019 Medical Communications, Research and Development ADHD, AEVI-001, Aevi Genomic Medicine, clinical trial failure, pharma

Aevi Genomic Medicine, a US drugmaker based outside of Philadelphia, has seen its share value plummet by 75% following the …
News
takeda_usa_pharmaceuticals_u

Takeda unveils three new discovery and development collaborations in immuno-oncology

January 4, 2019 Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma

Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …
News
38707779504_4778627b30_z

Top Ten most popular articles on Pharmafile.com of 2018!

December 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026